The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 23, 2021
Filed:
Sep. 02, 2015
Applicant:
Nitto Denko Corporation, Osaka, JP;
Inventors:
Assignee:
NITTO DENKO CORPORATION, Osaka, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 31/047 (2006.01); A61K 31/05 (2006.01); A61K 31/085 (2006.01); A61K 31/355 (2006.01); A61K 31/4184 (2006.01); A61K 31/4192 (2006.01); A61K 31/663 (2006.01); A61K 31/675 (2006.01); A61K 31/685 (2006.01); A61K 33/00 (2006.01); A61K 31/42 (2006.01); A61K 31/192 (2006.01); A61K 31/12 (2006.01); A61K 9/70 (2006.01); A61K 38/00 (2006.01); A61K 31/19 (2006.01); A61K 31/4375 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61K 31/415 (2006.01); A61K 31/196 (2006.01); A61K 9/06 (2006.01); A61K 31/09 (2006.01); A61K 31/194 (2006.01); A61K 31/198 (2006.01); A61K 31/216 (2006.01); A61K 31/235 (2006.01); A61K 31/352 (2006.01); A61K 31/353 (2006.01); A61K 31/37 (2006.01); A61K 31/375 (2006.01); A61K 31/405 (2006.01); A61K 31/407 (2006.01); A61K 31/421 (2006.01); A61K 31/4745 (2006.01); A61K 31/5415 (2006.01); A61K 31/616 (2006.01); A61K 31/635 (2006.01); A61K 31/7048 (2006.01); A61K 33/04 (2006.01); A61K 38/10 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0005 (2013.01); A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 9/7023 (2013.01); A61K 9/7053 (2013.01); A61K 9/7061 (2013.01); A61K 31/047 (2013.01); A61K 31/05 (2013.01); A61K 31/085 (2013.01); A61K 31/09 (2013.01); A61K 31/12 (2013.01); A61K 31/19 (2013.01); A61K 31/192 (2013.01); A61K 31/194 (2013.01); A61K 31/196 (2013.01); A61K 31/198 (2013.01); A61K 31/216 (2013.01); A61K 31/235 (2013.01); A61K 31/352 (2013.01); A61K 31/353 (2013.01); A61K 31/355 (2013.01); A61K 31/37 (2013.01); A61K 31/375 (2013.01); A61K 31/405 (2013.01); A61K 31/407 (2013.01); A61K 31/415 (2013.01); A61K 31/4184 (2013.01); A61K 31/4192 (2013.01); A61K 31/42 (2013.01); A61K 31/421 (2013.01); A61K 31/4375 (2013.01); A61K 31/4745 (2013.01); A61K 31/5415 (2013.01); A61K 31/616 (2013.01); A61K 31/635 (2013.01); A61K 31/663 (2013.01); A61K 31/675 (2013.01); A61K 31/685 (2013.01); A61K 31/7048 (2013.01); A61K 33/00 (2013.01); A61K 33/04 (2013.01); A61K 38/00 (2013.01); A61K 38/10 (2013.01); A61K 39/00 (2013.01); A61K 45/06 (2013.01);
Abstract
The present invention aims to provide a vaccine pharmaceutical composition universally usable for induction of cellular immunity against various antigens and exerting a high cellular immunity inducing effect. The present invention relates to a vaccine pharmaceutical composition for inducing cellular immunity, containing: an antigen; and a first cellular immunity induction promoter that is a bisphosphonate.